We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Boston Scientific on Acquisition Spree

By HospiMedica staff writers
Posted on 15 Mar 2001
Following its agreement to acquire Interventional Technologies in mid-February for US$345 million, Boston Scientific (Natick, MA, USA) has recently acquired or agreed to acquire three more companies.

Boston Scientific has acquired Embolic Protection, Inc. More...
(EPI, Campbell, CA, USA) for $75 million. EPI has developed an embolic protection device, which is mounted on a guidewire and used to capture embolic material that is dislodged during cardiovascular interventions. The acquisition allows Boston Scientific to enter the embolic protection market, which it believes is one of the most promising new growth segments in interventional medicine.

Catheter Innovations (Salt Lake City, UT, USA) has also been acquired by Boston Scientific, expanding the latter's holdings in the $500 million venous access market. Terms were not disclosed. Catheter Innovations develops and markets catheter-based venous access products used for the delivery of chemotherapy drugs, antibiotics, and nutritional support. The company offers a complete line of products that incorporate its Pressure-Activated Safety Valve (PASV) protection technology. This acquisition will complement the less-invasive offerings of the Medi-tech division of Boston Scientific.

Boston Scientific has agreed to acquire Quanam Medical Corp. (Santa Clara, CA, USA). Quanam develops medical devices using novel polymer technology, with a focus on drug-delivery stent systems for use in cardiovascular applications. Terms were not disclosed. Quanam's drug-delivery stent incorporating a paclitaxel derivative is in a pivotal clinical trial in Europe. Boston Scientific also has a paclitaxel-coated stent in clinical trials in Europe.



Related Links:
Boston Scientific

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.